1. Home
  2. KLTO vs CPHI Comparison

KLTO vs CPHI Comparison

Compare KLTO & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTO
  • CPHI
  • Stock Information
  • Founded
  • KLTO 2019
  • CPHI N/A
  • Country
  • KLTO United States
  • CPHI China
  • Employees
  • KLTO N/A
  • CPHI N/A
  • Industry
  • KLTO
  • CPHI Biotechnology: Pharmaceutical Preparations
  • Sector
  • KLTO
  • CPHI Health Care
  • Exchange
  • KLTO NYSE
  • CPHI Nasdaq
  • Market Cap
  • KLTO 5.0M
  • CPHI 4.5M
  • IPO Year
  • KLTO N/A
  • CPHI N/A
  • Fundamental
  • Price
  • KLTO $0.16
  • CPHI $1.65
  • Analyst Decision
  • KLTO
  • CPHI
  • Analyst Count
  • KLTO 0
  • CPHI 0
  • Target Price
  • KLTO N/A
  • CPHI N/A
  • AVG Volume (30 Days)
  • KLTO 152.3K
  • CPHI 119.7K
  • Earning Date
  • KLTO 05-15-2025
  • CPHI 05-14-2025
  • Dividend Yield
  • KLTO N/A
  • CPHI N/A
  • EPS Growth
  • KLTO N/A
  • CPHI N/A
  • EPS
  • KLTO N/A
  • CPHI N/A
  • Revenue
  • KLTO N/A
  • CPHI $4,528,929.00
  • Revenue This Year
  • KLTO N/A
  • CPHI N/A
  • Revenue Next Year
  • KLTO N/A
  • CPHI N/A
  • P/E Ratio
  • KLTO N/A
  • CPHI N/A
  • Revenue Growth
  • KLTO N/A
  • CPHI N/A
  • 52 Week Low
  • KLTO $0.11
  • CPHI $1.20
  • 52 Week High
  • KLTO $13.10
  • CPHI $4.10
  • Technical
  • Relative Strength Index (RSI)
  • KLTO N/A
  • CPHI 42.78
  • Support Level
  • KLTO N/A
  • CPHI $1.34
  • Resistance Level
  • KLTO N/A
  • CPHI $1.71
  • Average True Range (ATR)
  • KLTO 0.00
  • CPHI 0.28
  • MACD
  • KLTO 0.00
  • CPHI 0.00
  • Stochastic Oscillator
  • KLTO 0.00
  • CPHI 37.38

About KLTO KLOTHO NEUROSCIENCES INC

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

Share on Social Networks: